iBio (IBIO) Liabilities from Discontinued Operations (2022 - 2024)

iBio (IBIO) has 3 years of Liabilities from Discontinued Operations data on file, last reported at 1933000.0 in Q1 2024.

• On a quarterly basis, Liabilities from Discontinued Operations fell 0.57% year-over-year to 1933000.0 in Q1 2024; TTM through Mar 2024 was 1933000.0, a 0.57% decrease from a year earlier, with the FY2023 full-year figure at 1941000.0, up 3366.07% from the prior year.
• Liabilities from Discontinued Operations for Q1 2024 stood at 1933000.0, roughly flat from 1936000.0 in the prior quarter.
• Over the last five years, Liabilities from Discontinued Operations for IBIO reached as high as 1947000.0 in Q4 2022 and fell as low as 56000.0 in Q2 2022.
• Historically, Liabilities from Discontinued Operations has averaged 1670857.14 across 3 years, with a median of 1939000.0 in 2023.
• Across the five-year window, Liabilities from Discontinued Operations soared 3366.07% in 2023 and dropped 0.57% in 2024, its largest moves.
• Year by year, Liabilities from Discontinued Operations stood at 1947000.0 in 2022, then dropped by 0.56% to 1936000.0 in 2023, then dropped by 0.15% to 1933000.0 in 2024.
• Per Business Quant data, the three most recent Liabilities from Discontinued Operations figures were 1933000.0 in Q1 2024, 1936000.0 in Q4 2023, and 1939000.0 in Q3 2023.